Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01) Download the PDF here. This post appeared first on investingnews.com 0 admin Website Related Posts WGC: Surging Gold Prices Drive Record Q2 Investment Demand August 5, 2025 OTCQB Venture Virtual Investor Conference Agenda Announced for August 7th August 5, 2025 Fortune Bay Announces Option Agreement for the Woods Uranium Projects August 5, 2025